2,255 results on '"Miravitlles, Marc"'
Search Results
2. Effect of different types of supervised exercise programs on cardiorespiratory and muscular fitness, pain, fatigue, mental health and inflammatory and oxidative stress biomarkers in older patients with post-COVID-19 sequelae “EJerSA-COVID-19”: a randomized controlled trial
3. Poor sleep quality, COPD severity and survival according to CASIS and Pittsburgh questionnaires
4. The prevalence of bronchiectasis in patients with alpha-1 antitrypsin deficiency: initial report of EARCO
5. COVID-19’s impact on care practice for alpha-1-antitrypsin deficiency patients
6. Correction: Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry
7. Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial
8. N-acetylcysteine Treatment in Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis/Pre-COPD: Distinct Meta-analyses
9. The Natural History of Severe Chronic Obstructive Pulmonary Disease: The SPOCCAT Study Protocol
10. Alpha-1 Antitrypsin Augmentation and the Liver Phenotype of Adults With Alpha-1 Antitrypsin Deficiency (Genotype Pi∗ZZ)
11. Sex-Differences in Alpha-1 Antitrypsin Deficiency: Data From the EARCO Registry
12. Potential systemic effects of acquired CFTR dysfunction in COPD
13. Association between occupational exposure and chronic obstructive pulmonary disease and respiratory symptoms in the Spanish population
14. Poor sleep is associated with deficits of attention in COPD patients
15. Alpha-1 antitrypsin (AAT) augmentation therapy in individuals with the PI*MZ genotype: a pro/con debate on a working hypothesis.
16. Assessment and monitoring of lung disease in patients with severe alpha 1 antitrypsin deficiency: a european delphi consensus of the EARCO group
17. Risk of lung disease in the PI*SS genotype of alpha-1 antitrypsin: an EARCO research project
18. Utility of the Enhanced Liver Fibrosis score as a blood biomarker of pulmonary fibrosis secondary to SARS-CoV-2 pneumonia
19. Inhaled Maintenance Therapy in the Follow-Up of COPD in Outpatient Respiratory Clinics. Factors Related to Inhaled Corticosteroid Use. EPOCONSUL 2021 Audit
20. Tobacco Patterns and Risk of Chronic Obstructive Pulmonary Disease: Results From a Cross-Sectional Study
21. Leveraging CT Imaging to Detect COPD and Concomitant Chronic Diseases
22. WED-135-YI Impact of metabolic alterations on liver phenotype of patients with homozygous alpha-1 antitrypsin deficiency (Pi*ZZ)
23. TOP-141 Longitudinal assessment of individuals with homozygous alpha-1 antitrypsin deficiency (Pi*ZZ genotype) provides evidence for clinical patient management
24. Estimated Worldwide Prevalence of the PI*ZZ Alpha-1 Antitrypsin Genotype in Subjects With Chronic Obstructive Pulmonary Disease
25. Variations in Chronic Obstructive Pulmonary Disease Outpatient Care in Respiratory Clinics: Results From the 2021 EPOCONSUL Audit
26. Trends of COPD in Spain: Changes Between Cross Sectional Surveys 1997, 2007 and 2017
27. Dissociation between physical capacity and daily physical activity in COPD patients. A population-based approach
28. Motivation and confidence about physical activity in COPD patients: health benefits matter to patients.
29. Characteristics and treatment patterns of patients with asthma on multiple-inhaler triple therapy in Spain
30. Determinants of blood eosinophil levels in the general population and patients with COPD: a population-based, epidemiological study
31. Feasibility of a genotyping system for the diagnosis of alpha1 antitrypsin deficiency: a multinational cross-sectional analysis
32. New variants of alpha-1-antitrypsin: structural simulations and clinical expression
33. Exercise capacity and physical activity in COPD patients treated with a LAMA/LABA combination: a systematic review and meta-analysis
34. Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry
35. Impaired pulmonary and muscle function during moderate exercise in female patients recovered from SARS-CoV-2
36. Effectiveness of Treatment With Dual Bronchodilation (LABA/LAMA) Compared With Combination Therapy (LABA/ICS) for Patients With COPD: A Population-Based Study
37. Concomitant inhaled corticosteroid use and the risk of pneumonia in COPD: a matched-subgroup post hoc analysis of the UPLIFT® trial
38. [Translated article] Spanish COPD Guideline (GesEPOC) Update: Comorbidities, Self-Management and Palliative Care
39. [Translated article] Spanish COPD Guidelines (GesEPOC 2021): Non-pharmacological Treatment Update
40. Actualización de la Guía Española de la EPOC (GesEPOC): comorbilidades, automanejo y cuidados paliativos
41. Actualización 2021 de la Guía Española de la EPOC (GesEPOC). Tratamiento no farmacológico
42. Efficacy and safety of discontinuing antibiotic treatment for uncomplicated respiratory tract infections when deemed unnecessary. A multicentre, randomized clinical trial in primary care
43. [Translated article] Spanish COPD Guidelines (GesEPOC) 2021 Update. Diagnosis and Treatment of COPD Exacerbation Syndrome
44. Actualización 2021 de la guía española de la EPOC (GesEPOC). Diagnóstico y tratamiento del síndrome de agudización de la EPOC
45. [Translated article] Spanish COPD guidelines (GesEPOC) 2021: Updated pharmacological treatment of stable COPD
46. Effectiveness and Safety of Inhaled Antibiotics in Patients With Chronic Obstructive Pulmonary Disease. A Multicentre Observational Study
47. Actualización 2021 de la Guía Española de la EPOC (GesEPOC). Tratamiento farmacológico de la EPOC estable
48. Personalised indication of augmentation therapy for emphysema associated with severe alpha-1 antitrypsin deficiency: a case series.
49. Leveraging Computed Tomography Imaging to Detect Chronic Obstructive Pulmonary Disease and Concomitant Chronic Diseases.
50. Genetic Epidemiology of Alpha-1 Antitrypsin Deficiency in Macaronesia.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.